PIRS Shares Outstanding History



Below is a table of the PIRS shares outstanding history going back to 9/12/2014:

Date PIRS Shares Outstanding
9/12/20146.10M
9/30/20146.10M
11/13/20146.25M
12/8/20140.01B
3/27/201529.43M
4/29/201529.43M
5/12/201529.43M
6/26/201539.04M
8/13/201539.73M
11/9/201539.76M
3/20/201639.83M
5/9/201639.83M
8/7/201643.06M
11/7/201643.06M
3/20/201743.06M
5/9/201743.07M
8/8/201744.31M
11/7/201744.79M
3/12/201853.86M
5/9/201853.97M
8/8/201854.03M
11/5/201854.15M
3/11/201949.15M
5/6/201949.17M
8/5/201949.39M
12/31/201859.52M
11/7/201954.98M
3/9/202055.21M
5/6/202052.32M
8/3/202052.40M
10/30/202055.97M
3/29/202159.72M
5/12/202163.30M
8/2/202166.71M
10/29/202172.06M
2/24/202274.08M
5/5/202274.10M
8/1/202274.41M
11/1/202274.41M
3/28/202374.52M
5/8/202382.02M
8/7/202398.85M
11/9/202398.85M
3/8/202498.94M

Also see: PIRS Market Cap History
PIRS YTD Return
PIRS Historical Shares Outstanding:
+34.11% CAGR
PIRS Historical Shares Outstanding: +34.11% CAGR

Mouse over chart for data details
9/12/2014 ...3/8/2024
Pieris Pharmaceuticals is a biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways. Co.'s clinical pipeline includes elarekibep an inhaled IL-4Ra antagonist Anticalin protein to treat uncontrolled asthma, PRS-220, an inhaled CTGF antagonist to treat IPF and other forms for fibrotic lung disease, an immuno-oncology (IO) bispecific PRS-344/S095012 targeting PD-L1 and 4-1BB. Co. has intellectual property rights directed to various aspects of its Anticalin technology platform, allowing for the development and improvement of both its platform and drug candidates. Co.'s development plans focus on its clinical and preclinical programs. We show 44 historical shares outstanding datapoints in our coverage of PIRS's shares outstanding history.

Understanding the changing numbers of PIRS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PIRS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PIRS by allowing them to research PIRS shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree PIRS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Pieris Pharmaceuticals (PIRS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

PKI Shares Outstanding History
PLRX Shares Outstanding History
PLSE Shares Outstanding History
PLUR Shares Outstanding History
PLXP Shares Outstanding History
PMCB Shares Outstanding History
PMD Shares Outstanding History
PMVP Shares Outstanding History
PNT Shares Outstanding History
POAI Shares Outstanding History
More Healthcare companies »

 

PIRS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.